Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-α-MSH in humans

Photochemistry and Photobiology

Volumn 72, Issue 4, 2000, Pages 526-532

  Dorr, Robert T ^a,d   Dvorakova, Katerina ^a   Brooks, Christine ^a   Lines, Ruskin ^a   Levine, Norman ^a   Schram, Karl ^b   Miketova, Petra ^b   Hruby, Victor ^c   Alberts, David S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Department of Chemistry ^*  (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; AMINOHYDROXYPHENYLALANINE; BENZENE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; MELANIN; PYRROLE 2,3,5 TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FACE; FEMALE; FOREARM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NECK; NORMAL HUMAN; SKIN BIOPSY; SKIN PIGMENTATION;

ADULT; ALPHA-MSH; FEMALE; HUMANS; MALE; MELANINS; MIDDLE AGED; SKIN; SKIN PIGMENTATION;

EID: 0034309807     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2000)072<0526:IEEATI>2.0.CO;2     Document Type: Article

References (43)

1. Lerner, A. B. and J. S. McGuire (1961) Effect of alpha- and beta-melanocyte stimulating hormones on the skin colour of man. Nature 189, 176-179.
2. McGuinness, B. W. (1963) Melanocyte-stimulating hormone: a clinical and laboratory study. Ann. N. Y. Acad. Sci. 100, 641-657.
3. Levine, N., S. N. Sheftel, T. Eytan, R. T. Dorr, M. E. Hadley, J. C. Weinrach, G. A. Ertl, K. Toth, D. L. McGee and V. J. Hruby (1991) Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. J. Am. Med. Assoc. 266, 2730-2736.
4. Dorr, R. T., T. Lines, N. Levine, C. Brooks, L. Xiang, V. J. Hruby and M. E. Hadley (1996) Pilot phase I trial of a superpotent cyclic melanotropic peptide in 3 normal volunteers. Life Sci. 58, 1777-1784.
5. Lerner, A. B. and J. S. McGuire (1964) Melanocyte-stimulating hormone and adrenocorticotrophic hormone: Their relation pigmentation. N. Engl. J. Med. 270, 539-546.
6. McArthur, R. G., M. D. Cloutier, A. B. Hayles and R. G. Sprague (1972) Cushing's disease in children: findings in 13 cases. Mayo Clin. Proc. 47, 318-326.
7. Schauer, E., F. Trautinger, A. Kock, A. Schwartz, R. Bhardwaj, M. Simon, J. C. Answel, T. Schwartz and T. A. Luger (1994) Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93, 2258-2262.
8. Hruby, V. J., S. D. Sharma, K. Toth, J. Y. Jaw, F. al-Obeidi, T. K. Sawyer, A. M. and M. E. Hadley (1993) Design, synthesis, and conformation of superpotent and prolonged acting melantropins. Ann. N. Y. Acad. Sci. 31, 51-63.
9. Sawyer, T. K., P. J. Sanfilippo, V. J. Hruby, M. H. Engel, C. B. Heward, J. B. Burnett and M. E. Hadley (1980) 4-Norleucine,7-D-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultra long biological activity. Proc. Natl. Acad. Sci. USA 77, 5754-5758.
10. 7]α-MSH. Invest. New Drugs 6, 251-258.
11. Dawson, B. V., C. A. Ford, H. Holloway, R. T. Dorr and P. Johnson (1993) Administration of melanotropic peptides during gestation in the rodent. Toxicology 77, 91-101.
12. 7α-melanocyte-stimulating hormone increases the eumelanin: phaeomelanin ratio in cultured human melanocytes. J. Invest. Dermatol. 104, 83-85.
13. United States Pharmacopeial 23, National Formulary 18, Sterility Tests (1995) United States Pharmacopeial Convention, Rockville, pp. 1688-1689.
14. Sullivan, Jr., J. D., F. W. Valois and S. W. Watson (1976) Endotoxins: the limulus amebocyte lysate system. In Mechanisms of Bacterial Toxicology (Edited by A. W. Bernheimer), pp. 217-220. Wiley, New York.
15. Ito, S. and K. Fujita (1985) Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Analytical Biochem. 144, 527-536, 1985.
16. Ito, S. (1993) High-performance liquid chromatography (HPLC) analysis of eu- and pheo-melanin in melanogenesis control. J. Invest. Dermatol. 100, 166S-171S.
17. Ito, S. and K. Jimbow (1983) Quantitative analysis of eumelanin and pheomelanin in hair and melanomas. J. Invest. Dermatol. 80, 268-272.
18. Ito, S. and K. Wakamatsu (1994) An improved modification of permanganate oxidation of eumelanin that gives a constant yield of pyrrole-2,3,5-tricarboxylic acid. Pigment Cell. Res. 7, 141-144.
19. Fitzpatrick, T. B. (1988) The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 124, 869-871.
20. Sayre, R. M., D. L. Desrochers and C. J. Wilson (1981) Skin type, minimum erythema dose (MED), and sunlight acclimatization. J. Am. Acad. Dermatol. 2, 439-443.
21. Westerhof, W., S. Pavel, A. Kammeyer, F. D. Beusenberg and R. Cormane (1987) Melanin-related metabolites as markers of the skin pigmentary system. J. Invest. Dermatol. 89, 78-81.
22. Porges, S. B., K. H. Kaidbey and G. L. Grove (1988) Quantification of visible light-induced melanogenesis in human skin. Photodermatology 5, 197-200.
23. Seitz, J. C. and C. G. Whitmore (1988) Measurements of erythematous and tanning responses in human skin using a tristimulus colorimeter. Dermatologica 177, 70-75.
24. 7-α-MSH (Melanotan-I) on tanning: a dose-ranging study. J. Dermatol. Treat. 10, 127-132.
25. Prota, G. (1980) Recent advances in the chemistry of melanogenesis in mammals. J. Invest. Dermatol. 75, 122-127.
26. Thody, A. J., E. M. Higgins, K. Wakamatsu, S. Ito, S. A. Burchill and J. M. Marks (1991) Pheomelanin as well as eumelanin is present in human epidermis. J. Invest. Dermatol. 97, 340-344.
27. Agin, P. P., R. M. Sayre and M. R. Chedekel (1980) Photodegradation of phaeomelanin: an in vitro model. Photochem. Photobiol. 31, 359-362.
28. Chedekel, M. R., P. P. Agis and R. M. Sayre (1980) Photochemistry of pheomelanin: action spectrum for superoxide production. Photochem. Photobiol. 31, 553-555.
29. Szabo, G. (1954) The number of melanocytes in human epidermis. Br. Med. J. 1, 1016-1017.
30. Valverde, P., E. Healy, I. Jackson, J. L. Rees and A. J. Thody (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genetics 11, 328-330.
31. Vitaliano, P. P. and F. Urbach (1980) The relative importance of risk factors in non-melanoma carcinoma. Arch. Dermatol. 116, 454-456.
32. Burchill, S. A., S. Ito and A. J. Thody (1993) Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J. Endocrinol. 137, 189-195.
33. Kwon, B. S., M. Wakulchik, A. Q. Haq, R. Halaban and D. Kestler (1988) Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expression. Biochem. Biophys. Res. Commun. 153, 1301-1309.
34. Hoganson, G. E., F. Ledwitz-Rigby, R. L. Davidson and B. B. Fuller (1989) Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melancyte-stimulating hormone and cyclic AMP. Som. Cell. Mol. Genet. 15, 255-263.
35. Wong, G. and J. Pawelek (1975) Melanocyte stimulating hormone promotes activation of preexisting tyrosinase molecules in Cloudman S91 melanoma cells. Nature 255, 644-646.
36. Halaban, R., S. H. Pomerantz, S. Marshall and A. B. Lerner (1984) Tyrosinase activity and abundance in Cloudman melanoma cells. Arch. Biochem. Biophys. 230, 383-387.
37. Burchill, S. A., A. J. Thody and S. Ito (1986) Melanocyte-stimulating hormone, tyrosinase, activity and the regulation of eumelanogenesis and phaeomelanogenesis in the hair follicular melanocytes of the mouse. J. Endocrinol. 109, 15-21.
38. Tamate, H. B. and T. Takeuchi (1984) Action of the e locus of mice in the response of phaeomelanic hair follicles to alpha-melanocyte stimulating hormone in vitro. Science 224, 1241-1242.
39. Jackson, I. J. (1993) Molecular genetics. Colour-coded switches. Nature 362, 587-588.
40. Robbins, L. S., J. H. Nadeau, K. R. Johnson, M. A. Kelley, L. Roselli-Rehfuss, E. Baack, K. G. Mountjoy and R. D. Cone (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834.
41. Mountjoy, K. G., L. S. Robbins, M. J. Low and R. D. Cone (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
42. Gantz, I. Y., Y. Shimoto, Y. Konda, H. Miwa, C. J. Dickinson and T. Yamada (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1214-1220.
43. Dorr, R. T., R. Lines, N. Levine, C. Brooks, L. Xiang, V. J. Hruby and M. E. Hadley (1996) Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 58, 1777-1784.